Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A neurofibroma characterized by the presence of cellular pleomorphism.
Biomarker and diagnostic research for atypical neurofibroma has been reported in the published literature.
4 clinical trials registered, 1 recruiting. Interventions under study include other interventions and drug therapy. Pipeline includes 1 PHASE1, 1 NA. Research is primarily sponsored by academic and government institutions.
15 publications have been identified in PubMed for atypical neurofibroma. Research spans Case Report / Case Series (60%), Diagnostic / Biomarker (13%), and Basic Science / Preclinical (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 9 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 3:28 AM UTC
Testing and diagnosis research | 2 | 13% |
Laboratory research | 2 | 13% |
Other research | 1 | 7% |
Research summaries | 1 | 7% |
Brunet A (2026). [PMID: 42071244](https://pubmed.ncbi.nlm.nih.gov/42071244/). *Acta Neuropathol Commun*. [Basic Science / Preclinical]
Román-Mendoza NM (2026). [PMID: 42135588](https://pubmed.ncbi.nlm.nih.gov/42135588/). *Int J Surg Pathol*. [Review / Meta-Analysis]
Tallone R (2026). [PMID: 41939448](https://pubmed.ncbi.nlm.nih.gov/41939448/). *Frontiers in oncology*. [Case Report / Case Series]
Alhawsawi W (2026). [PMID: 41716749](https://pubmed.ncbi.nlm.nih.gov/41716749/). *Case Rep Dermatol*. [Case Report / Case Series]
Zhang X (2025). [PMID: 40630199](https://pubmed.ncbi.nlm.nih.gov/40630199/). *Frontiers in oncology*. [Case Report / Case Series]
Gaydarski L (2025). [PMID: 40700245](https://pubmed.ncbi.nlm.nih.gov/40700245/). *Reports (MDPI)*. [Case Report / Case Series]
Corliss LE (2025). [PMID: 41343818](https://pubmed.ncbi.nlm.nih.gov/41343818/). *Journal of neurosurgery. Case lessons*. [Case Report / Case Series]
Lucas CG (2025). [PMID: 39500722](https://pubmed.ncbi.nlm.nih.gov/39500722/). *Neuro-oncology*. [Diagnostic / Biomarker]
Zhang Z (2025). [PMID: 40308487](https://pubmed.ncbi.nlm.nih.gov/40308487/). *Frontiers in oncology*. [Case Report / Case Series]
Wang Y (2025). [PMID: 40225101](https://pubmed.ncbi.nlm.nih.gov/40225101/). *JGH Open*. [Case Report / Case Series]